Drug Database · Clinicians

Fimasartan

Brands (1) KanarbShow all

Angiotensin II antagonist PH FDA category

Rx · Prescription drug2 PH productsVAT-exempt
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Film-coated tablet: 60 mg, 120 mg

Registered products in the Philippines

2 products registered with the Food and Drug Administration (FDA) Philippines list Fimasartan as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Fimasartan
Package insert
KanarbFimasartan potassium (as trihydrate)
120 mg Film-Coated TabletPVC/PE/PVDC-Aluminum Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Boryung CorporationKorea
Zuellig Pharma Corporation
DR-XY46262
Feb 28, 2028
KanarbFimasartan potassium (as trihydrate)
60 mg Film-Coated TabletPVC/PE/PVDC-Aluminum Blister Pack x 10's (Box of 30's)
RxVAT-exempt
Boryung CorporationKorea
Zuellig Pharma Corporation
DR-XY46261
Feb 28, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .